Medicare Enrolled

Dr. Steven Gerhardt, MD

Neurology · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
8390 LYNDON B JOHNSON FWY STE 1000, Dallas, TX 75243
2147509977
In practice since 2006 (19 years)
NPI: 1972609766 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gerhardt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gerhardt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gerhardt

Dr. Steven Gerhardt is a neurology in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Gerhardt performed 1,864 Medicare services across 1,193 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gerhardt received a total of $9,195 from 76 pharmaceutical and/or device companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gerhardt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 20% volume in TX$ $9,195 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,864
Medicare services
Top 20% in TX for neurology
1,193
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~98 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)359$93$215
Needle measurement of electrical activity in arm or leg muscles, complete study347$78$267
Neuromuscular re-education therapy, per 15 min159$23$141
Physical therapy exercise, per 15 min155$19$141
Office visit, established patient, complex (40-54 min)140$135$275
New patient office visit, complex (60-74 min)137$160$535
Nerve conduction, 9-10 studies102$170$547
Functional activity therapy85$26$122
Group therapy session40$11$50
Initial hospital admission, high complexity40$129$300
Hospital follow-up visit, moderate complexity39$63$175
Nerve conduction, 13 or more studies36$226$698
Nerve conduction, 7-8 studies30$138$492
Nerve conduction, 11-12 studies24$200$605
Mri scan of brain without contrast22$108$879
Needle measurement of electrical activity in arm or leg muscles, limited study21$50$204
Evaluation of neuropsychological test, first hour20$97$325
Administration of psychological or neuropsychological test by technician, first 30 minutes20$27$225
Administration of psychological or neuropsychological test by technician, each additional 30 minutes20$28$225
Hospital follow-up visit, high complexity18$91$256
Mri scan of upper spinal canal without contrast16$95$872
New patient office visit (45-59 min)12$120$425
Mri scan of lower spinal canal without contrast11$105$965
Measurement of brain wave activity (eeg), awake and drowsy11$305$752
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,195
Total received (2018-2024)
Avg $1,314/year across 7 years
Top 29% in TX for neurology
76
Companies
495
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,925 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$270 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,854
2023
$1,105
2022
$830
2021
$254
2020
$705
2019
$2,292
2018
$2,154

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,019
UCB, Inc.
$603
Biogen, Inc.
$569
Novartis Pharmaceuticals Corporation
$457
Genentech USA, Inc.
$442
Alexion Pharmaceuticals, Inc.
$343
Acorda Therapeutics, Inc
$298
PFIZER INC.
$278
Adamas Pharmaceuticals, Inc.
$274
Amgen Inc.
$268
Sunovion Pharmaceuticals Inc.
$257
ACADIA Pharmaceuticals Inc
$228
CSL Behring
$228
Lilly USA, LLC
$218
Grifols USA, LLC
$214
Teva Pharmaceuticals USA, Inc.
$193
Lundbeck LLC
$168
Abbott Laboratories
$163
Supernus Pharmaceuticals, Inc.
$162
EMD Serono, Inc.
$150
Celgene Corporation
$149
Neurocrine Biosciences, Inc.
$145
Eisai Inc.
$129
Amneal Pharmaceuticals LLC
$122
Merz Pharmaceuticals, LLC
$115
Marinus Pharmaceuticals, Inc.
$101
Upsher-Smith Laboratories LLC
$98
GENZYME CORPORATION
$96
Allergan, Inc.
$86
AbbVie Inc.
$78
Octapharma USA, Inc.
$76
ARGENX US, INC.
$72
Sumitomo Pharma America, Inc.
$70
Mallinckrodt Enterprises LLC
$68
Neurelis, Inc.
$67
MERZ NORTH AMERICA, INC.
$64
TG Therapeutics, Inc.
$59
GE Healthcare
$53
Ipsen Biopharmaceuticals, Inc
$51
Akcea Therapeutics, Inc.
$51
Averitas Pharma Inc.
$49
HOSPIRA, INC.
$48
GE HEALTHCARE
$47
Merz North America, Inc.
$42
US WorldMeds, LLC
$42
Allergan Inc.
$42
Bayer HealthCare Pharmaceuticals Inc.
$39
Mitsubishi Tanabe Pharma America, Inc.
$35
Alnylam Pharmaceuticals Inc.
$34
ASSERTIO THERAPEUTICS, Inc.
$34
Avanir Pharmaceuticals, Inc.
$33
Currax Pharmaceuticals LLC
$29
ARBOR PHARMACEUTICALS, INC.
$26
JAZZ PHARMACEUTICALS INC.
$26
Horizon Therapeutics plc
$25
CATALYST PHARMACEUTICALS, INC.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$23
Mallinckrodt LLC
$22
AbbVie, Inc.
$22
IMPEL PHARMACEUTICALS INC.
$21
Vertical Pharmaceuticals, LLC
$21
Life Molecular Imaging Ltd
$20
SCILEX PHARMACEUTICALS INC.
$19
AQUESTIVE THERAPEUTICS, INC.
$19
EISAI INC.
$18
Aprecia Pharmaceuticals, LLC
$18
Itamar Medical Inc
$17
Otsuka America Pharmaceutical, Inc.
$17
ANI Pharmaceuticals, Inc.
$16
Janssen Pharmaceuticals, Inc
$15
PORTOLA PHARMACEUTICALS, INC.
$14
Arbor Pharmaceuticals, Inc.
$13
Assertio Therapeutics, Inc.
$13
Xeris Pharmaceuticals, Inc.
$12
Scilex Pharmaceuticals Inc.
$11
Retrophin, Inc.
$10
Top 3 companies account for 23.8% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BRIUMVI · Betaseron · Briviact · CONFIRM RX · COPAXONE · Cambia · DAYBUE · DIVIGEL · DUOPA · DYSPORT · Deep Brain Stimulation · Dysport · EMGALITY · EPIDIOLEX · Enspryng · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAYZENT · MYOBLOC · Mavenclad · NEURACEQ · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · PANZYGA · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SYMPAZAN · Skyclarys · Soliris · Spritam · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WatchPATONE · XEOMIN · Xadago · Xeomin · ZEPOSIA · ZTALMY · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $493 per 100 Medicare services performed
Looking for a neurology in Dallas?
Compare neurologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
237
Per 100K population
9.1
County median income
$74,149
Nearest hospital
NEXUS CHILDRENS HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gerhardt is a clinical cardiology specialist, with above-average Medicare volume (top 20% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gerhardt experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gerhardt performed 359 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gerhardt receive payments from pharmaceutical companies?
Yes. Dr. Gerhardt received a total of $9,195 from 76 companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gerhardt's costs compare to other neurologys in Dallas?
Dr. Gerhardt's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gerhardt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →